BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01100944-completion@plaintrial.com
DTSTAMP:20260928T161436Z
DTSTART;VALUE=DATE:20151021
SUMMARY:A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cispla
 tin\, Doxorubicin and Cyclophosphamide in the First Line Treatment of Adva
 nced or Recurrent Thymic\, Malignancies — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT01100944
URL:https://plaintrial.com/trial/NCT01100944
END:VEVENT
END:VCALENDAR